CVM Supplier Qualification & Vendor Management 2 — Questions and Answers
Question 1: Under ICH Q10, which supplier management activity falls under the responsibility of the manufacturer's pharmaceutical quality system?
- Directing the supplier's internal production scheduling
- Oversight of outsourced activities and quality of purchased materials (Correct answer)
- Developing the supplier's internal SOPs and validation protocols
- Managing the supplier's employee training programs
Correct answer: Oversight of outsourced activities and quality of purchased materials
ICH Q10 explicitly states that the pharmaceutical quality system must include oversight of outsourced activities and quality of purchased materials, placing ultimate accountability on the manufacturer.
Question 2: A supplier notifies your organization of a planned change to their manufacturing process for a critical excipient. What is the correct first step under a supplier change management program?
- Immediately suspend shipments from the supplier until the change is approved
- Assess the potential impact of the change on your product quality and validation status (Correct answer)
- Issue a supplier corrective action request (SCAR) for unauthorized process modification
- Update the Approved Supplier List to reflect the change as received
Correct answer: Assess the potential impact of the change on your product quality and validation status
A formal impact assessment determines whether the supplier change affects product quality, regulatory filings, or validated processes before any disposition decision is made.
Question 3: What is the purpose of a Supplier Corrective Action Request (SCAR)?
- To formally request a price reduction following a quality failure
- To document and track required corrective actions after a supplier quality failure or audit finding (Correct answer)
- To notify the supplier that they have been removed from the Approved Supplier List
- To establish new quality specifications for materials purchased from the supplier
Correct answer: To document and track required corrective actions after a supplier quality failure or audit finding
A SCAR is a formal communication requiring the supplier to investigate a quality failure, identify root cause, and implement verified corrective actions within a defined timeframe.
Question 4: Which EU GMP Annex most specifically addresses the qualification and oversight of contract manufacturers and laboratories?
- Annex 1 — Manufacture of Sterile Medicinal Products (Correct answer)
- Annex 11 — Computerised Systems
- Annex 16 — Certification by a Qualified Person
- Annex 7 — Manufacture of Herbal Medicinal Products
Correct answer: Annex 1 — Manufacture of Sterile Medicinal Products
EU GMP Chapter 7 (not an Annex) governs outsourced activities; however, Annex 1 contains specific contractor provisions for sterile manufacturing. For contract work broadly, EU GMP Chapter 7 is the primary reference — a validation manager must know both.
Question 5: During a supplier qualification audit, which finding would be considered most critical from a GMP compliance perspective?
- Minor delays in updating internal SOPs following process improvements
- Absence of documented cleaning validation for equipment shared between different product campaigns (Correct answer)
- Slightly longer-than-recommended training intervals for non-GMP staff
- Use of a paper-based rather than electronic batch record system
Correct answer: Absence of documented cleaning validation for equipment shared between different product campaigns
Lack of cleaning validation for shared equipment presents a direct cross-contamination risk to product quality and patient safety, making it the most critical finding among the options.
Question 6: How should supplier performance metrics typically be structured in a vendor management program?
- Based solely on delivery timeliness and competitive pricing
- Using quality indicators such as CoA compliance rate, rejection rate, SCAR response time, and audit findings trends (Correct answer)
- Focused exclusively on financial stability and capacity indicators
- Measured only during formal re-qualification audits conducted every five years
Correct answer: Using quality indicators such as CoA compliance rate, rejection rate, SCAR response time, and audit findings trends
Effective supplier performance metrics combine quality-based indicators — rejection rates, CoA compliance, SCAR closure times, and audit trends — to provide an ongoing, risk-based view of supplier reliability.
Question 7: When should a manufacturer initiate re-qualification of an already approved supplier?
- Only when the supplier requests re-evaluation after making improvements
- Exclusively on a fixed 3-year cycle regardless of performance history
- When triggered by significant changes, quality failures, audit findings, or as defined by the risk-based requalification schedule (Correct answer)
- Only if the FDA issues a warning letter to the supplier
Correct answer: When triggered by significant changes, quality failures, audit findings, or as defined by the risk-based requalification schedule
Re-qualification is triggered by risk-based criteria including significant supplier changes, recurring quality failures, unsatisfactory audit findings, or when the defined periodic review interval has elapsed.
CVM Supplier Qualification & Vendor Management 2
Under ICH Q10, which supplier management activity falls under the responsibility of the manufacturer's pharmaceutical quality system?